SOT is a key event for Cyprotex allowing us to showcase our latest research to the industry. We were authors on 12 posters and presented at two joint exhibitor sessions along with DILIsym Services, Inc and Cellular Dynamics International. Learn more about our new research below.
In March, Cyprotex solidified its close relationship with DILIsym and signed a co-marketing agreement to promote the benefits of the collaboration in helping to elucidate drug induced liver injury. Find out more about our recent joint poster where we unravelled the mechanism of TAK-875 hepatotoxicity.
In April, our Head of ADME, Dr Phil Butler will be presenting at the in-cosmetics® global conference in London. The presentation will be focused on skin metabolism and the value of in vitro methods in understanding the routes of metabolism in skin.
Cyprotex scientists will also be attending the British Toxicology Society (BTS) Annual Congress in Liverpool, UK from 3rd-5th April 2017. Visit stand 1 or get in touch with us to arrange an appointment with our scientific experts.